InVirtuoLabs aims to halve development time and costs in pharmaceutical research using artificial intelligence and advanced molecular simulations
InVirtuoLabs has raised €2.9M across 1 funding round, most recently a round in Feb 2025. Based in Lugano, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-20 | Other | €2.9M |
| — |
| View deal → |
